A detailed history of Deep Track Capital, LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 6,000,000 shares of GH stock, worth $163 Million. This represents 4.09% of its overall portfolio holdings.

Number of Shares
6,000,000
Previous 5,000,000 20.0%
Holding current value
$163 Million
Previous $135 Million 8.48%
% of portfolio
4.09%
Previous 5.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$17.13 - $26.91 $17.1 Million - $26.9 Million
1,000,000 Added 20.0%
6,000,000 $124 Million
Q4 2023

Feb 14, 2024

BUY
$21.58 - $29.5 $20.5 Million - $28 Million
950,000 Added 23.46%
5,000,000 $135 Million
Q3 2023

Nov 14, 2023

BUY
$25.8 - $39.97 $65.8 Million - $102 Million
2,550,000 Added 170.0%
4,050,000 $120 Million
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $31.4 Million - $57 Million
1,500,000 New
1,500,000 $53.7 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.77B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.